The European Commission has granted conditional marketing authorization for Ojemda (tovorafenib) as monotherapy for the treatment of patients 6 months of age and older with pediatric low-grade-glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation, who have progressed after one or more prior systemic therapies.
Ronald McDonald House New York announced the completion of its renovation of the Community Floor, a reimagined space designed to enhance the everyday experience of children and families staying at the House while their children receive treatment for serious illnesses. The project, which has transformed dining, kitchen, play, and program areas on the second floor of the House at 405 East 73rd Street, creates spaces where families can share meals, children can play and learn, and caregivers can find opportunities for connection, respite, and support.
